Norstella

Citeline Podcasts

Citeline places biopharma and medical device professionals, and those who focus on these industries, at the forefront of knowledge and insight, by providing the perfect combination of news and information together with penetrating insight and analysis. Citeline is a leader in the field of healthcare industry information.

Koniecznie odwiedź stronę podcastu i wesprzyj twórcę: www.citeline.com

Autor

Norstella

Kategoria

Business

Strona podcastu

www.citeline.com

Ostatni odcinek

19 lis 2026

Gdzie słuchać?

Podcasty w aplikacji Replaio Radio Już wkrótce

Podcasty trafią do aplikacji już wkrótce. Zainstaluj teraz i jako pierwszy zobacz nowe podejście do podcastów

Pobierz z Google Play Zainstaluj za darmo Android 10 mln+ pobrań · ocena 4,7+ iOS wkrótce

Odcinki

Optimise Clinical Trial Execution with Smarter Outsourcing and Patient-Focused Design 25.05.2026

"Biotechs are running increasingly complex clinical trials with lean teams, tight budgets, and growing pressure to deliver faster results. In this episode, Claire Riches, VP, Clinical Solutions, Citeline is joined by Carrie Melvin, Head of Clinical Operations and Data Management, Lantheus to explore how smarter outsourcing, stronger CRO partnerships, and patient‑focused trial design can improve ex...

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) May 25, 2026 25.05.2026

本期播客内容来自《Scrip》杂志,精选内容涵盖截至2026年5月22日当周的生物制药行业的商业动态。本期节目采用人工智能文本转语音及语音仿真技术制作。 本期要闻: 行业正努力应对最惠国待遇政策带来的影响;早期临床试验进展迅速推动中国市场合作;艾伯维(AbbVie)寻求在神经科学领域扩张;环状DNA会是下一个重大突破吗?;以及Regeneron公司的fianlimab遭遇挫折。 Story links: https://insights.citeline.com/scrip/podcasts/scr...

Drug Fix: What’s Next For US FDA After Senior Leadership Purge 22.05.2026

Pink Sheet Executive Editor Derrick Gingery, Senior Reporter Maaisha Osman, Senior Editor Sue Sutter and Editor-in-Chief Nielsen Hobbs discuss the impact of the US Food and Drug Administration’s purge of multiple center directors and other senior executives in the wake of Commissioner Martin Makary’s resignation (:34). They also discuss the agency’s potential new direction and the initial comments...

MHRA’s Rob Reid updates on timings for CE marking, pre-market SI and possible EU MDR outcomes 22.05.2026

MHRA’s Rob Reid spoke to Ashley Yeo at MTF 2026 on issues affecting UK and Great Britain medtech regulation

Europe’s Evolving Role in Global Clinical Trials 18.05.2026

As global clinical development strategies evolve, Europe is emerging as a critical hub for scientific innovation, operational agility, and patient recruitment — reshaping its role in the future of clinical trials. In this episode, Scott Davis, Vice President of Clinical Services at Novotech, joins Andrew Warmington from Citeline to explore how sponsors are rethinking Europe’s place in global devel...

Scrip Deals Podcast: An Interview With Jeremy Levin 18.05.2026

Ovid Therapeutics Chairman Jeremy Levin talks with Scrip about how the US should view its biotech sector as a strategic national asset and urges the venture capital sector to place more emphasis on supporting early and innovative science.

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) May 18, 2026 18.05.2026

本期播客内容来自《Scrip》杂志,精选内容涵盖截至2026年5月15日当周的生物制药行业的商业动态。本期节目采用人工智能文本转语音及语音仿真技术制作。 本期要闻: 葛兰素史克(GSK)强化下游肥胖症战略;诺和诺德(Novo)在早期肥胖症口服药市场占据优势; 罗氏对瑞士的支持面临压力;恒瑞与百时美施贵宝达成重大研发联盟;PCSK9药物Lerochol在美国以更低的直接成本上市。 Story links: https://insights.citeline.com/scrip/podcas...

Scrip's Five Must-Know Things - May 18, 2026 18.05.2026

Audio roundup of selected biopharma industry content from Scrip over the business week ended May 15, 2026. This episode was produced with the help of AI text-to-voice and voice emulation tools. This time – GSK bolsters downstream obesity strategy; Novo winning early obesity pill market; Roche’s support for Switzerland under strain; Hengrui and BMS strike huge R&D alliance; PCSK9 drug Lerochol laun...

Drug Fix: Post-Mortem On Martin Makary’s Tenure As FDA Commissioner 15.05.2026

Pink Sheet Executive Editor Derrick Gingery, Senior Reporter Maaisha Osman, Senior Editor Sue Sutter, Editor-in-Chief Nielsen Hobbs, as well as special guest Mike McCaughan, founding member of Prevision Policy, discuss the circumstances and mistakes that lead to Martin Makary’s resignation as head of the US Food and Drug Administration (:38), his achievements during his short term (21:56), the age...

ABHI's Steve Lee on the UK MHRA's frictionless regulatory future for the UK 15.05.2026

The MHRA’s spring 2026 CE-marking consultation, the progress of UK medtech statutory instruments and the European Commission’s proposed revision of the MDR and IVDR were top of mind for the Association of British HealthTech Industries' Steve Lee as he did the rounds – and the panels – at the MedTech Forum 2026.

The Generics Bulletin Podcast: Biosimilars Conference Report And Big M&A Deals 14.05.2026

Generics Bulletin's editorial team discusses the recent Medicines for Europe biosimilars conference, attended by deputy editor Dean Rudge; while editor Dave Wallace talks about the latest big deals in biosimilars and what is behind them.

Kurma’s €215m Fund And What It Says About European Funding Environment 14.05.2026

Kurma Partners has closed BioFund IV at €215m — its largest fund to date, but roughly €35m short of its initial target. For partner Amanda Gett-Chaperot, that gap is more than a fundraising footnote: it points to a structural problem that has long constrained European biotech's ability to build at US scale. Tags: Venture capital, European biotech, Fundraising, Exits, Early-stage investment

The Scrip Awards Podcast - Call For Entries 2026, New AI Category, Triana Interview 12.05.2026
Podcast: Inside Arcutis with CEO Frank Watanabe 12.05.2026

Arcutis Biotherapeutics' CEO Frank Watanabe joins In Vivo’s David Wild to talk about building a patient‑first culture and turning a three‑person startup into a commercial‑stage immunodermatology company. He explains how Zoryve (roflumilast) is reshaping care in chronic inflammatory skin diseases, why Arcutis is pushing beyond dermatology offices into primary care and pediatrics, and how new assets...

How Agentic AI Could Reshape Consumer Health, With IQVIA’s Volker Spitzer 11.05.2026

In the latest episode of HBW Insight's Over the Counter podcast, Volker Spitzer, vice-president, global R&D/RWE services at IQVIA Consumer Health, returns to examine the implications of agentic AI for the consumer health industry – a topic he and colleagues explore in a recently published white paper. Unlike the large language models now familiar to most consumers, agentic AI operates with persist...

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) May 11, 2026 11.05.2026

本期播客内容来自《Scrip》杂志,精选内容涵盖截至2026年5月8日当周的生物制药行业的商业动态。本期节目采用人工智能文本转语音及语音仿真技术制作。 本期要闻: 诺和诺德抢占早期口服减肥药市场;葛兰素史克(GSK)交易强化其下游减肥药战略;辉瑞因Vyndamax和解协议前景转好; 中国主导创纪录的新药上市;以及强生公司放弃两款淋巴瘤CAR-T疗法。 Story links: https://insights.citeline.com/scrip/podcasts/scrips-five-must-kno...

Scrip's Five Must-Know Things - May 11, 2026 11.05.2026

Audio roundup of selected biopharma industry content from Scrip over the business week ended May 8, 2026. This episode was produced with the help of AI text-to-voice and voice emulation tools. This time – Novo winning early oral obesity market; GSK deal bolsters downstream obesity strategy; brighter Pfizer outlook due to Vyndamax settlements; China dominates record novel drug launches; and J&J dro...

Drug Fix: US FDA’s Makary Pressured To Resign, Continues Hiring, Reform Efforts 08.05.2026

Pink Sheet Executive Editor Derrick Gingery, Senior Reporter Maaisha Osman and Editor-in-Chief Nielsen Hobbs consider the increasing pressure on US Food and Drug Administration Commissioner Martin Makary to resign and its long-term impact on the agency (:34). They also discuss Makary’s comments on patient anecdotes influencing regulatory decisions on psychedelic drugs and his new AI-enabled one-da...

Forum chief Gwyn Tudor puts the case for medtech development in Wales 08.05.2026

BioWales Podcast: Getting Medtech Right In A Small Country Maximizing The Tailwind From BioWales 2026 Gwyn Tudor, head of the MediWales forum, lays out the challenges, opportunities and funding on offer for healthtech founders who make Wales part of their strategic plan. For healthtech companies looking to move from start-up to manufacturing and scale-up, Wales can be an attractive location, with...

Drug Fix: The New Acting US FDA Biologics Center Director, SCOTUS Eyes Generic Drug Policy 01.05.2026

Pink Sheet Executive Editor Derrick Gingery, Senior Reporter Maaisha Osman, Senior Editor Sue Sutter, Editor-in-Chief Nielsen Hobbs and Generics Bulletin Executive Editor Dave Wallace discuss US Food and Drug Administration Commissioner Martin Makary’s appointment of Katherine Szarama as acting Center for Biologics Evaluation and Research director and the updated timeline for find a permanent dire...

Carna Health On Closing the Gap in CKD Prevention 01.05.2026

Salvatore Viscomi, CEO and co-founder of Carna Health, discussed the company's pivotal work to combat the global crisis of chronic kidney disease (CKD).

What To Expect After China’s First siRNA Firm Went Public 30.04.2026

In this episode of the China biopharma English-language podcast, Xu Hu talks about the siRNA area, including possible industry and R&D environment changes for Chinese firms developing these therapies and trends in deals of China-originated siRNA assets this year. Story link: Chinese siRNA Contenders Set For Transitions, Deals In 2026

Five-Minute Podcast: Chris Jones On Wales' Life Sciences Innovation Hub 28.04.2026

The Life Sciences Hub Wales supports on oncology and cardiovascular disease technologies which are ideally at TRL6. Improved health outcomes is among the aims  of the LSHW as it decides where to place its support. Chris Jones of LSHW explained the rationale to Medtech Insight at BioWales 2026.   

Cracking China's Consumer Health Market, With QIVA Global's Ellie Adams 28.04.2026

In the latest episode of the Over The Counter podcast, HBW Insight speaks with Ellie Adams, founder and CEO of QIVA Global – a strategy and operating partner to international consumer healthcare brands entering the Chinese market. Adams, who has spent more than two decades working in China, offers a frank, insider perspective on what it really takes to succeed in the world's second-largest consume...

Genyro’s Adrian Woolfson on Artificial Biological Intelligence and Genome Writing 27.04.2026

In this In Vivo podcast, David Wild speaks with Adrian Woolfson, co-founder, president and CEO of Genyro, about how high-fidelity DNA writing and AI-driven genome design could reshape biopharma R&D, from accelerating program design and iteration speed to enabling civilizational-scale applications like DNA-based data storage and ultra-fast vaccine manufacturing. Woolfson, a physician-scientist, exp...

Słuchaj podcastu Citeline Podcasts w Replaio

Radio i podcasty w jednej aplikacji - za darmo, bez zakładania konta. Zainstaluj już dziś i nie przegap premiery

Pobierz z Google Play

Replaio nie jest wydawcą podcastów; nazwy audycji, okładki i audio należą do ich autorów i są rozpowszechniane przez publiczne kanały RSS